Literature DB >> 31954592

Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life.

John R Hurst1, Neil Skolnik2, Gerald J Hansen3, Antonio Anzueto4, Gavin C Donaldson5, Mark T Dransfield6, Precil Varghese7.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) represent a significant clinical problem, and are associated with decreased lung function, worsening quality of life and decreased physical activity levels, with even a single exacerbation having detrimental effects. The occurrence of COPD exacerbations can also have a considerable impact on healthcare costs and mortality rates, with over one-fifth of patients hospitalized for a COPD exacerbation for the first time dying within one year of discharge. This highlights the need for COPD exacerbations to be a major focus in clinical practice. Furthermore, the substantial effect that COPD exacerbations can have on patient mental health should not be underestimated. Despite their clinical importance, COPD exacerbations are poorly recognized and reported by patients, and improving patient understanding and reporting of exacerbations to ensure prompt treatment may minimize their deleterious effects. Renewed focus on improving current clinical practice with support from evidence-based guidelines is required. This also raises a challenge to payors, healthcare systems and government policies to do more to tackle the considerable outstanding burden of COPD exacerbations.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comorbidity; Mental health; Mortality; Physical functional performance; Quality of life; Respiratory function tests

Mesh:

Year:  2020        PMID: 31954592     DOI: 10.1016/j.ejim.2019.12.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  14 in total

1.  Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care.

Authors:  Anne Meiwald; Rupert Gara-Adams; Aleix Rowlandson; Yixuan Ma; Henrik Watz; Masakazu Ichinose; Jane Scullion; Tom Wilkinson; Mohit Bhutani; Georgie Weston; Elisabeth J Adams
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-01

2.  Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.

Authors:  Kirsty Rhodes; Martin Jenkins; Enrico de Nigris; Magnus Aurivillius; Mario Ouwens
Journal:  BMC Med Res Methodol       Date:  2022-05-25       Impact factor: 4.612

3.  AND-ASPEN and ESPEN consensus, and GLIM criteria for malnutrition identification in AECOPD patients: a longitudinal study comparing concurrent and predictive validity.

Authors:  Bruna Espíndola de Araújo; Veronnike Kowalski; Giovana Molon Leites; Jaqueline da Silva Fink; Flávia Moraes Silva
Journal:  Eur J Clin Nutr       Date:  2021-10-26       Impact factor: 4.884

4.  Clinical features predicting COVID-19 mortality risk.

Authors:  Hamidreza Kouhpayeh
Journal:  Eur J Transl Myol       Date:  2022-04-12

5.  Remote Patient Monitoring Technologies for Predicting Chronic Obstructive Pulmonary Disease Exacerbations: Review and Comparison.

Authors:  Kathleen G Fan; Jess Mandel; Parag Agnihotri; Ming Tai-Seale
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-21       Impact factor: 4.773

Review 6.  Towards precision in defining COPD exacerbations.

Authors:  Christine R Jenkins
Journal:  Breathe (Sheff)       Date:  2021-09

Review 7.  Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts' review.

Authors:  Raja Dhar; Deepak Talwar; Sundeep Salvi; B V Muralimohan; Sagar Panchal; Saiprasad Patil; Sagar Bhagat; Nishtha Khatri; Hanmant Barkate
Journal:  ERJ Open Res       Date:  2022-03-28

8.  Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.

Authors:  Jaber S Alqahtani; Tope Oyelade; Abdulelah M Aldhahir; Saeed M Alghamdi; Mater Almehmadi; Abdullah S Alqahtani; Shumonta Quaderi; Swapna Mandal; John R Hurst
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

9.  Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.

Authors:  Line Hust Storgaard; Hans-Ulrich Hockey; Ulla Møller Weinreich
Journal:  BMJ Open Respir Res       Date:  2020-11

Review 10.  Nature-Based Interventions for Psychological Wellbeing in Long-Term Conditions: A Systematic Review.

Authors:  Eleanor M Taylor; Noelle Robertson; Courtney J Lightfoot; Alice C Smith; Ceri R Jones
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.